Elysium Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeElysium Therapeutics
Elysium Therapeutics logo

Elysium Therapeutics

0 followers

About Elysium Therapeutics

Elysium Therapeutics is a biotech company focusing on safer medicines and overdose prevention. It develops SMART products designed to outlast potent synthetic opioids like fentanyl and reduce adverse events, including opioid overdoses. Its portfolio includes SOOPR Naloxone, a long-acting rescue agent for fentanyl-related overdoses, and O2P Oral Overdose Protection, a self-limiting opioid delivery system to reduce misuse and overdose. The company emphasizes addressing the opioid crisis with innovative countermeasures aimed at improving public health safety, particularly in the United States.

Recent News

Recent Deals

Key Team Members

Greg Sturmer

Co-Founder & CEO

Tom Jenkins

Co-Founder & CSO

Key Facts

HQ Location

Akron, United States

Founded

2013

Employees

1 - 10

Status

Private

Website

https://elysiumrx.com